COMMUNIQUÉS West-GlobeNewswire

-
Aclaris Therapeutics to Attend Upcoming Investor Conferences
28/11/2018 -
Emerald Health Therapeutics Announces Executive Chairman Avtar Dhillon Appointed as President; CEO Chris Wagner Steps Down
28/11/2018 -
Medigus Announces Third Quarter 2018 Financial Results
28/11/2018 -
Sunesis Pharmaceuticals to Provide Program Update for Non-Covalent BTK-Inhibitor Vecabrutinib at Analyst & Investor Event during ASH 2018
28/11/2018 -
Share issue / transfer in connection with reduction of the quantity of shares in Nexstim Plc
28/11/2018 -
ChromaDex to Present at the 11th Annual LD Micro Main Event
28/11/2018 -
Affimed to Host Research & Development Day on Friday, December 7, 2018 in New York City
28/11/2018 -
Invivoscribe soumet le test de mutation LeukoStrat CDx FLT3 à la fois aux États-Unis et au Japon pour soutenir la soumission de Daiichi Sankyo pour le quizartinib
28/11/2018 -
Aquarius Surgical Technologies Announces Appointment of Mr. Gordon Willox as President & CTO, and the Closing of Funding Transaction
28/11/2018 -
Olainfarm invites to Third Quarter 2018 Investor Conference Webinar
28/11/2018 -
Sysmex and MolecularMD Commence Global Partnership to Address the Challenges in Companion Diagnostics Development and Commercialization
28/11/2018 -
INSTI HIV Self Test Earns WHO Prequalification Status for Home Testing
28/11/2018 -
B-Temia and Wistron Announce the Incorporation of B-Temia Asia
28/11/2018 -
B-Temia et Wistron annoncent la création de B-Temia Asia
28/11/2018 -
ObsEva SA Announces Initiation of Phase 3 IMPLANT 4 Trial of Nolasiban in Europe, Canada and Russia for Improving IVF Outcomes
28/11/2018 -
B-Temia and Wistron Announce the Incorporation of B-Temia Asia
28/11/2018 -
B-Temia et Wistron annoncent la création de B-Temia Asia
28/11/2018 -
Abattis Comments on BCSC Temporary Order
28/11/2018 -
Coherus BioSciences Announces New Employment Inducement Grants
28/11/2018
Pages